Evidence map›Paper›PMID 36080093›Full record

ArticleNanomaterials (Basel, Switzerland)2022

The Release of Non-Extractable Ferulic Acid from Cereal By-Products by Enzyme-Assisted Hydrolysis for Possible Utilization in Green Synthesis of Silver Nanoparticles.

Vitalijs Radenkovs, Karina Juhnevica-Radenkova, Dmitrijs Jakovlevs, Peteris Zikmanis, Daiga Galina, Anda Valdovska

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vitalijs RadenkovsProcessing and Biochemistry Department, Institute of Horticulture, LV-3701 Dobele, Latvia.ORCID 0000-0001-9443-3525
Karina Juhnevica-RadenkovaProcessing and Biochemistry Department, Institute of Horticulture, LV-3701 Dobele, Latvia.
Dmitrijs JakovlevsResearch Laboratory of Biotechnology, Division of Smart Technologies, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.
Peteris ZikmanisProcessing and Biochemistry Department, Institute of Horticulture, LV-3701 Dobele, Latvia.
Daiga GalinaResearch Laboratory of Biotechnology, Division of Smart Technologies, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.ORCID 0000-0003-0784-7354
Anda ValdovskaResearch Laboratory of Biotechnology, Division of Smart Technologies, Latvia University of Life Sciences and Technologies, LV-3004 Jelgava, Latvia.ORCID 0000-0003-2044-5042
Latvia University of Life Sciences and Technologies · LV

Funding

Strengthening of the scientific capacity at LLU Project No. Z-68 "Demonstrating the efficiency of grain-derived by-product biorefining process for sustainable release of non-extractable bioactives with potential applicability in green synthesis of silver nanoparticles"
6 · The paper itself

Abstract

The present work was undertaken to elucidate the potential contribution of biosynthetically produced ferulic acid (FA) via enzymatic hydrolysis (EH) of rye bran (RB) to the formation of silver nanoparticles (AgNPs) during green synthesis. An analytical approach accomplished by multiple reaction monitoring (MRM) using triple quadrupole mass selective detection (HPLC-ESI-TQ-MS/MS) of the obtained hydrolysate revealed a relative abundance of two isomeric forms of FA, i.e.,

Indexed as

biocompositesbiorefiningby-productsenzymatic hydrolysisgreen synthesisnanoparticlesnano-scale objects

Identifiers

PMID36080093
PMCPMC9458256
OpenAlexW4295086852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.